Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoxia common cold granules phase II dose-finding trial
CTR20241012Phase 2Completed
- Sponsor
- Yiling Pharmaceutical
- Start
- Mar 2024
- Countries
- 1
01
Overview
A Phase 2 trial of Huoxia Cold Granules in nasopharyngitis, sponsored by Yiling Pharmaceutical. Started Mar 2024; status: completed.
02
Drugs
Huoxia Cold Granules
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20241012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241012.